Mesenchymal Stem Cell Homing to the Chronically Injured Liver

Medicine & Life Sciences

1. Hepacivirus 100%
2. Liver Diseases 98%
3. Liver 91%
4. Virus Diseases 79%
5. Liraglutide 75%
6. Hepatitis A virus 70%
7. Non-alcoholic Fatty Liver Disease 70%
8. Fatty Liver 67%
9. Liver Function Tests 61%
10. Protease Inhibitors 55%
11. General Practice 53%
12. Fibrosis 50%
13. Meta-Analysis 50%
14. Interferons 49%
15. Immunosuppression 48%
16. Mesenchymal Stem Cells 48%
17. Superinfection 43%
18. Vaccination 43%
19. Clone Cells 42%
20. Primary Health Care 42%
21. Type 2 Diabetes Mellitus 40%
22. Data Analysis 40%
23. Prospective Studies 38%
24. Liver Transplantation 38%
25. Cohort Studies 36%
26. Guidelines 34%
27. Safety 31%
28. Enzymes 29%
29. Kidney 28%
30. Mortality 27%
31. Vascular Cell Adhesion Molecule-1 24%
32. Uncertainty 24%
33. Vaccines 20%
34. Genotype 19%
35. Placebos 18%
36. Glomerular Filtration Rate 17%
37. Cellular Senescence 11%
38. Wounds and Injuries 11%
39. Liver Cirrhosis 10%
40. Plastics 10%
41. Weight Loss 8%
42. Therapeutics 8%
43. Odds Ratio 8%
44. Costs and Cost Analysis 8%
45. Alcohol Drinking 8%
46. Signs and Symptoms 7%
47. Diet Therapy 7%
48. Tacrolimus 6%
49. Glucagon-Like Peptide 1 6%
50. Practice Guidelines 6%
51. Growth 5%